UCL-TB

TB Events

UCL WORLD TB DAY MEETING: Monday 25 March
Targeting zero deaths from TB: progress, reality and hope

Professor Tim McHugh (email) was host of this this year’s UCL World TB Day. The event was run in conjunction with The Lancet Infectious Diseases (Lancet link) which published a series of articles edited by Professor Ali Zumla, UCL Centre for Clinical Microbiology. 

Link to our events page to read the blog see the photos from the day.

North London TB Journal Club

Organiser: Dr Rob Aldridge (email)
Link to North London TB Journal Club site: http://northlondontb.org/

Thursday 20 June, 2013 - 12 midday

6 versus 36-month isoniazid preventive treatment – which is best?

Paper: Samandari et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 2011; 377: 1588–98.

Isoniazid preventive treatment (IPT), is one of the 3 I’s advocated in the World Health Organisation TB/HIV strategy. Several large IPT trials have reported recently. Join us to discuss one. The paper is available here and full details of the journal club are below.

Chair: Prof Ibrahim Abubakar, Centre for Infectious Disease Epidemiology, UCL.

Presenter: Laura Munoz, Centre for Infectious Disease Epidemiology, UCL.

Venue: Duncan Catterall room on the Lower Ground floor at the Mortimer Market Centre.

Directions: The Mortimer Market Centre is in a courtyard off Capper Street, close to Tottenham Court Road

TB News

MAMS-TB trial (Multi-arm-multi-stage-TB): leading European and African clinicians commence a new trial that may lead to shorter tuberculosis treatment. [May 2013]

The PanACEA consortium (Pan African Consortium for the Evaluation of Anti-tuberculosis agents) have started recruiting patients to an innovative new clinical trial of tuberculosis (TB) treatments. The aim of this trial is to identify new treatment regimens that could significantly shorten the length of therapy from six months to three months. The trial is being conducted in Tanzania and South Africa and uses a new approach that could reduce the time taken to bring the treatment to market. The MAMS-TB trial (Multi-arm-multi-stage -TB) uses a combination of established drugs and novel drugs and is funded by the European Developing Country Clinical Trials Partnership (EDCTP). [Download the press release]

UCL WORLD TB DAY EVENT 2013

This week's World TB Day event at the Royal Free invited speakers to talk about targetting zero deaths from TB.  A selection of photographs from the event is available here (LINK) with copies speakers' presentations and a blogger's account to come shortly. (27 March).

Professor Tim McHugh: Inaugural Lecture (December 2012)

Professor McHugh delivered his inaugural lecture at UCL on 13 December, 2012, on the challenges of drug resistant TB. Link to video of lecture.

Professor Alimuddin Zumla: Presidential Award

Professor Ali Zumla has been awarded the Zambian Order of Distinguished Service (First Division) by the President of Zambia during the Zambia presidential award investiture ceremony on 24 October, during Zambia's independence day celebrations, at the Presidential State House in Lusaka. The award was made to recognise Professor Zumla's considerable achievements in medicine and international development.

TB Jobs

PhD in Mycobacterium tuberculosis

A PhD studentship is available to study the regulation of drug efflux mechanisms in Mycobacterium tuberculosis at the Royal Veterinary College under the supervision of Dr Sharon Kendall (RVC) and Professor Timothy McHugh (Centre for Clinical Microbiology, UCL). Details can be downloaded (WORD document) and applicants should contact Dr Kendall in the first instance (details in the document).

Deadline: 31 January, 2013.

Contact us

Tell us about your latest projects and events related to TB or ask us a question about TB.

Our email is  t.mchugh@ucl.ac.uk.

Join the mailing list